You are receiving this email as a subscriber to Pharmaceutical Executive |
| |
 |
|
Have You Seen PharmExec.com's New and Improved Site Design?
» Visit www.pharmexec.com to utilize our upgraded search engine, view expanded topic coverage, experience multimedia content, access content archives, and more.
Interested in Learning About Other Topics?
Give us your ideas for a Future Webcast or Podcast |
| |
| Featured Webcasts: |
Tuesday, May 25, 2010 at 11:00 AM ET; 8:00 AM PT
Moving Beyond Document Management to Enterprise Content Compliance
This webinar will examine the growing trend in the life sciences industry away from traditional document management systems to emerging Enterprise Content Compliance (ECC) solutions. You?ll learn how ECC solutions are changing and accelerating traditional regulatory document preparation by allowing companies to compress the time spent authoring and reviewing content for protocols, submissions, labeling, clinical trial disclosure, and other mandates.
|
| » Register Free! |
|
|
Thursday, May 20, 2010 at 11:00 AM ET; 8:00 AM PT
21 CFR Part 11, Computer Systems Validation and the Requirements of the FDA
Computer Systems Validation is an activity that presents complex challenges to the life sciences community. Conflicting information from the FDA and the evolution of multiple industry standards for technical data set validation including Good Automated Manufacturing Practice (GAMP) 4 and 5 have caused confusion and uncertainty within the industry. Join us to hear from industry and compliance experts that know the facts around computer systems validation. Hear about common challenges and how to overcome them. Discuss the definition and scope of validation (including SaaS solutions), identify what the FDA says about validation, and learn best practices that you can implement in your organization to help ensure your systems are compliant with FDA?s expectations and company business objectives.
|
| » Register Free! |
|
|
ON DEMAND
The Future of Commercial Models in Pharma
Today, many pharmaceutical executives are asking: How will we compete in a marketplace that, by 2015, will be 80% undifferentiated? What industry imperatives do we need to address in the design and implementation of our new commercial model? What does our organization need to do now in order to compete? Get the answers to these questions and more at the April 20 webcast, "The Future of Commercial Models in Pharma," where you?ll hear IMS experts describe how your organization needs to align with the market and organize for the future in order to design, and implement, the most efficient and effective commercial model.
|
|
ON DEMAND
SaaS or On-premise CRM - It's Your Choice... Not Your Vendor's
As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional 'single message to many' approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given the imperative to 'do more with less' your commercial organization may be re-evaluating the effectiveness of your Customer Relationship Management (CRM) system. What are the questions that you should be asking yourself and your vendor when considering a CRM investment? Please join us for a free live webcast, featuring a panel of industry experts who will share practical insights to help you define your organization?s current and future needs and determine what CRM capabilities are best suited meet them.
|
| » Register Free! |
|
|
|
|
Data Governance: Business Data You Can Believe In
Bad data – and a lack of good data management practices – can cost your business millions of dollars every year. You have to treat your data like every other valuable asset in your business: You must protect it, nurture it and ensure that, like any asset, it’s in the best condition possible.
|
| » View Whitepaper |
|
Safety Document Exchange in the Global Clinical Research Environment
Serious Adverse Event (SAE) reporting can have severe repercussions both for patient safety and company reputation. By choosing a portal solution from a SaaS provider with state-of-the-art online security features, a sponsor or CRO can maintain real-time distribution and access reports for all documents shared, helping maintain compliance and data privacy.
|
| » View Whitepaper |
|
|
|
|
|
| Featured Content: |
Industry Audit 2009
Cast against a backdrop of global recession and pressure on the business model that is blurring the traditional strategic divide between generic and originator products, St. Joseph's University Professor Bill Trombetta presents our Eighth Annual Pharma Industry Audit, which this year digs deeper into current business trends by adding 11 new companies to the survey.
|
|
Pharm Exec 50
We leap tall buildings to bring you the definitive guide to the world's leading pharma companies...The world's top 50 pharmaceutical companies accounted for prescription drug sales of $558 billion in 2008. Though a few more companies dipped into negative growth than last year, more than half of the list achieved double-digit growth, a sign that although recession eventually hits even pharma, it usually hits later than in many other industries. Who's in, who's back, and who's out?
| » More... |
|
|
2009's Emerging Leaders
What will the drug industry look like in 20 years? Can we get there? How? The faces of innovation…Meet 27 industry pioneers under age 45 who are bringing new ideas to life.
|
| » More…. |
|
|
|
|
|
B2M Productions/Getty Images
|
|
|
|
